A study of the safety, tolerability and pharmacokinetics of Intravenous (IV) and Powder for Oral suspension formulations of Posaconazol (POS) in Immunocompromised Pediatric Subjects with Neutropenia

Administered By

Awarded By

Contributors

Start/End

  • November 1, 2015 - April 30, 2019